Login / Signup

Systemic anticancer therapy near the end of life: an analysis of factors influencing treatment in advanced tumor disease.

N-S LeA ZeybekK HacknerS Gottsauner-WolfI GroissenbergerF JutzL TschurlovichJ SchediwyJ SingerG Kreye
Published in: ESMO open (2024)
The timing of SACT near the EOL is significantly influenced by several factors, including the type of SACT, referral to PC services, admission to PC unit, and ECOG performance status. These findings underscore the complexity of treatment decisions in advanced cancer care and highlight the need for personalized, patient-centered approaches that consider both clinical and patient-related factors to optimize care at the EOL.
Keyphrases
  • healthcare
  • primary care
  • stem cells
  • mental health
  • palliative care
  • quality improvement
  • combination therapy
  • mesenchymal stem cells